CIK 0001469443
- Non-accelerated filer
- Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810571538
- Phone
- +1 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 100 shares at $2.51 ($251)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Open-market sale Interim Chief Financ. Officer sold 8,280 shares at $2.49 ($20,645)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Interim Chief Financ. Officer sold 1,720 shares at $2.42 ($4,169)
- 4 Open-market sale Chief Scientific Officer sold 2,853 shares at an average $2.98 ($8,499)
- 4 Open-market sale Chief Scientific Officer sold 3,273 shares at an average $3.20 ($10,476)
- 3/A Insider 3/A
- 4 Open-market sale Chief Scientific Officer sold 1,666 shares at $3.00 ($5,003)
- 4 Open-market sale President and CEO sold 3,200 shares at an average $2.92 ($9,350)
- 4 Open-market sale Interim Chief Financ. Officer sold 10,035 shares at $3.57 ($35,788)
- 3/A Insider 3/A
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at an average $4.01 ($60,134)
- 4 Open-market sale Chief Scientific Officer sold 4,527 shares at $2.91 ($13,191)
- 4 Exercise or conversion President and CEO acquired 3,000 shares (option exercise)
- 4 Open-market sale President and CEO sold 5,145 shares at $3.01 ($15,469)
- 4 Open-market sale President and CEO sold 9,100 shares at an average $3.13 ($28,440)
Page 8 of 11 · 203 filings